$OMRI Omrix Biopharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Omrix Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Omrix Biopharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Omrix Biopharmaceuticals, Inc. for free.
IRS Number: 522147005
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: OMRI
Company Address: 630 FIFTH AVENUE, 22ND FLOOR NEW YORK 10111
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Omrix Biopharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Grant | A | 0.00 | 40,000 | 0 | 2,837,103 | 2.8 M to 2.8 M (+1.43 %) |
| Nov 05 2008 | OMRI | Omrix Biopharmaceu ... | Alperovitz Asaf | Chief Financial Off ... | Option Exercise | A | 13.25 | 60,000 | 795,000 | 60,000 | |
| Oct 30 2008 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | President and COO | Grant | A | 0.00 | 20,000 | 0 | 27,000 | 7 K to 27 K (+285.71 %) |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Option Exercise | A | 21.69 | 25,000 | 542,250 | 65,000 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 38,250 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 77,634 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Grant | A | 0.00 | 2,000 | 0 | 119,627 | 117.6 K to 119.6 K (+1.70 %) |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 41,000 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 2,000 | 0 | 6,000 | 4 K to 6 K (+50.00 %) |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 46,442 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Grant | A | 0.00 | 2,000 | 0 | 10,467 | 8.5 K to 10.5 K (+23.62 %) |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Option Exercise | A | 21.69 | 15,000 | 325,350 | 46,000 | |
| Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 3,000 | 0 | 5,000 | 2 K to 5 K (+150.00 %) |
| May 30 2008 | OMRI | Omrix Biopharmaceu ... | MCNAMARA PAMELA W | Director | Option Exercise | A | 15.16 | 20,000 | 303,200 | 0 |
View all Omrix Biopharmaceuticals, Inc. insider transactions.